ArticlePNAS nexus2025
Triangle weaver spiders construct spring-loaded webs using a novel set of genes for exceptionally proline-rich silk.
Article in PNAS nexus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spiders amplify their physical capabilities by synthesizing multiple high performing silks. Renowned for its toughness, major ampullate (MA) silk composes the spiderweb frame, providing support and absorbing high-energy impacts. In ecribellate orb-weavers, proline-rich motifs in MaSp2 proteins of MA silk are linked to a range of mechanical properties, including extensibility, elasticity, stiffness, and supercontraction. We show a modification of these motifs outside of this clade in a spider that constructs a spring-loaded web. The triangle weaver spider
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.